Muti-factorial assessments, including mitotic count, CDKN2A/B status, and CNVs, can differentiate between aggressive WHO grade 1 and well-behaved WHO grade 2 meningiomas, which is useful for risk stratification [86]. Here, CDKN2A is linked to meningioma.